Literature DB >> 17710972

Survival and outcome of very low birth weight infants born in a university hospital with level II NICU.

Suthida Sritipsukho1, Tipvapa Suarod, Paskorn Sritipsukho.   

Abstract

OBJECTIVES: Determine the survivals, neonatal outcomes to hospital discharge, and perinatal risks of death among VLBW infants born in the Thammasat University Hospital. MATERIAL AND
METHOD: This was a retrospective longitudinal study. Data were colleted from medical charts of all neonates with a gestational age of more than 25 weeks and birth weight of less than 1500 grams, who were born in Thammasat University Hospital for a 3-year period between July 1st, 2003 and June 30th, 2006. Antenatal history, perinatal data, and neonatal outcome until hospital discharge were extracted and analyzed.
RESULTS: Seventy-eight neonates with a birth weight between 600-1485 grams were analyzed. Survival rate of very-low-birth-weight (VLBW) infants and extremely-low-birth-weight (ELBW) infants were 81% and 52% respectively. Respiratory distress syndrome (RDS) was the major cause of death. Major morbidity was found in 35% of survived infants to hospital discharge. Unfavorable outcome was documented in infants with a birth weight < 750 grams. Perinatal risks of mortality among VLBW infants included no use of antenatal steroids (p = 0.015), gestational age of <28 weeks (p = 0.012), ELBW (p < 0.001), congenital abnormalities (p = 0.002), Apgar score at 5 minute <5 (p = 0.019), needed endotracheal intubation in the delivery room (p < 0.001), and first temperature at NICU < 35.0 degrees C (p = 0.023).
CONCLUSION: Overall survival and outcome among very-low-birth-weight infants born in Thammasat University Hospital is acceptable. The mortality and morbidity in extremely-low-birth-weight infants remained high. A continuing audit of these measures should be encouraged.

Entities:  

Mesh:

Year:  2007        PMID: 17710972

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  8 in total

1.  Outcome of esophageal atresia/tracheoesophageal fistula in extremely low birth weight neonates (<1000 grams).

Authors:  Augusto Zani; Justyna Wolinska; Giovanni Cobellis; Priscilla P L Chiu; Agostino Pierro
Journal:  Pediatr Surg Int       Date:  2015-10-30       Impact factor: 1.827

Review 2.  Positioning for acute respiratory distress in hospitalised infants and children.

Authors:  Abhishta P Bhandari; Daniel A Nnate; Lenny Vasanthan; Menelaos Konstantinidis; Jacqueline Thompson
Journal:  Cochrane Database Syst Rev       Date:  2022-06-06

3.  Determinants of survival in very low birth weight neonates in a public sector hospital in Johannesburg.

Authors:  Daynia E Ballot; Tobias F Chirwa; Peter A Cooper
Journal:  BMC Pediatr       Date:  2010-05-06       Impact factor: 2.125

Review 4.  Positioning for acute respiratory distress in hospitalised infants and children.

Authors:  Donna Gillies; Deborah Wells; Abhishta P Bhandari
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

5.  Mortality in extremely low-birth-weight neonates in méxico city (1985-2009).

Authors:  José Iglesias-Leboreiro; Isabel Bernardez-Zapata; José Ramírez-Haua; Rocco González-Morán; Mario Enrique Rendón-Macías
Journal:  Int J Pediatr       Date:  2010-12-21

6.  Second trimester amniocentesis is not a risk factor for very low birth weight and extremely low birth weight.

Authors:  Vincenzo Mazza; Mariangela Pati; Emma Bertucci; Carlotta Cani; Silvia Latella; Giancarlo Gargano; Antonio Percesepe; Annibale Volpe
Journal:  ISRN Obstet Gynecol       Date:  2011-08-03

7.  Prediction of neonatal deaths in NICUs: development and validation of machine learning models.

Authors:  Abbas Sheikhtaheri; Mohammad Reza Zarkesh; Raheleh Moradi; Farzaneh Kermani
Journal:  BMC Med Inform Decis Mak       Date:  2021-04-19       Impact factor: 2.796

8.  Outcome of very low birth weight infants over 3 years report from an Iranian center.

Authors:  Seyyed-Abolfazl Afjeh; Mohammad-Kazem Sabzehei; Minoo Fallahi; Fatemeh Esmaili
Journal:  Iran J Pediatr       Date:  2013-10       Impact factor: 0.364

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.